As the global pharmaceutical industry navigates the dynamic landscape of clinical research, China has firmly established its dominance in trial…
Read More

As the global pharmaceutical industry navigates the dynamic landscape of clinical research, China has firmly established its dominance in trial…
Read More
Two prominent forces in specialized healthcare investment, Global Healthcare Opportunities (GHO) and CBC Group, have announced a groundbreaking merger to…
Read More
The integration of NVIDIA’s accelerated computing and BioNeMo platform with QIAGEN Digital Insights’ bioinformatics capabilities is poised to usher in…
Read More
The field of ovarian cancer research is undergoing a profound transformation, driven by significant advancements in personalized medicine and innovative…
Read More
Regeneron Pharmaceuticals has announced a monumental research collaboration with Parabilis Medicines, a deal valued at an impressive $2.32 billion. This…
Read More
The United Kingdom has received a crucial supply of the antiviral medication favipiravir from the Japanese government, a strategic move…
Read More
VERTANICAL has announced a significant milestone in its development of VER-01, an investigational non-opioid therapeutic candidate for chronic low back…
Read More
Boehringer Ingelheim has achieved a significant milestone in the treatment of interstitial lung diseases with the approval of Jascayd (nerandomilast)…
Read More
The leadership landscape within the U.S. Department of Health and Human Services (HHS) is undergoing a significant and turbulent transformation,…
Read More
The World Health Organization (WHO) has officially declared the current Ebola disease outbreak in Sub-Saharan Africa a public health emergency…
Read More